药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Eltoprazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eltoprazine.
Potassium cation
Benperidol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benperidol.
Potassium cation
Tandospirone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tandospirone.
Potassium cation
TD-8954
The risk or severity of adverse effects can be increased when Cannabidiol is combined with TD-8954.
Potassium cation
Perazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Perazine.
Potassium cation
Ritanserin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ritanserin.
Potassium cation
Urapidil
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Urapidil.
Potassium cation
Indiplon
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Indiplon.
Potassium cation
AZD-3043
The risk or severity of adverse effects can be increased when Cannabidiol is combined with AZD-3043.
Potassium cation
Benzodiazepine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzodiazepine.
Potassium cation
Raclopride
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Raclopride.
Potassium cation
Piritramide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Piritramide.
Potassium cation
Ketanserin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ketanserin.
Potassium cation
Orvepitant
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Orvepitant.
Potassium cation
Bromperidol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromperidol.
Potassium cation
Esreboxetine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Esreboxetine.
Potassium cation
Piclozotan
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Piclozotan.
Potassium cation
Carisbamate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Carisbamate.
Potassium cation
Salvinorin A
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Salvinorin A.
Potassium cation
Eltanolone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eltanolone.